Elyssa Benedikt is a highly accomplished professional with a rich academic background in neurobiology and neurosciences from Dartmouth College. Benedikt has held prominent positions in several organizations throughout her career, including her current role at Sanofi Genzyme in the organization's Global Rare Disease Value & Access division. Benedikt has garnered invaluable experience from her previous roles at Sanofi Genzyme, including Global Lead, Hemophilia, and Associate Director, New Product Planning. Benedikt has also worked as a Consultant at Simon-Kucher & Partners and interned at the World Health Organization.

Benedikt has an impressive educational pedigree that includes studying at the MIT Sloan School of Management and the Harvard-MIT Division of Health Sciences and Technology. Benedikt has also worked as an intern at Millennium Pharmaceuticals.

Through her professional experience, Benedikt has demonstrated expertise in marketing and business development, new product planning, and multiple sclerosis. Benedikt is a highly skilled individual who is passionate about her work and is committed to achieving positive outcomes for her organization.